$EIDX: Eidos Therapeutics Announces Positive Phase 2 Data for AG10 in …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 (GLOBE NEWSWIRE) — Eidos Therapeutics, Inc. (Eidos) (NASDAQ:EIDX), today announced positive results of its Phase 2 clinical trial studying AG10 …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12675610/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptom

Related News:

$EIDX $MNK: Key events next week – healthcare

$EIDX: Eidos Therapeutics Receives Positive Opinion for Orphan …

$EIDX: Eidos Therapeutics to Present Phase 2 Data for AG10 in TTR …

$EIDX: FDA Grants Orphan Drug Designation to Eidos Therapeutics …

$PFE $ALNY $IONS $AKCA $EIDX $SPX: Pfizer stock drops 2% as positive rare-disease drug results won’t stop competitors

Latest News:

$BTE $KLIC: Should You Buy Baytex Energy Corp (BTE)?

$FICO $GOLD: Fair Isaac Corporation (FICO): Are Hedge Funds Right About This …

$UTHR: MannKind – Afrezza Scripts Hit Milestone As 2018 Comes To A Close

$JLL: Should You Buy Jones Lang LaSalle Inc (JLL)?

$INGN $OSK: Hedge Funds Are Crazy About Inogen Inc (INGN)

$BAM $ZTS $REGN: Is Brookfield Asset Management Inc. (BAM) A Good Stock To Buy?

$RNG $LOGI: Is Ingredion Inc (INGR) Going to Burn These Hedge Funds?

$FRT: Federal Realty Investment Trust (FRT) Hedge Funds Are Snapping Up

$HUBS $ICUI: Is HubSpot Inc (HUBS) A Good Stock To Buy?

$HUBG $GME $INSM: Hub Group Inc (HUBG) Hedge Funds Are Snapping Up

$BECN $MNK: Beacon Roofing Supply, Inc. (BECN): Are Hedge Funds Right About …